Global Column Agglutination Test Cards 麻豆原创 Growth 2024-2030

Publication ID:

LPI07241335

Publication Date:

July 12, 2024

Pages:

124

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

A Column Agglutination Test (CAT) card is a diagnostic tool used primarily in immunohematology to perform blood typing, antibody screening, and cross-matching. It employs a method similar to microcolumn gel cards, where agglutination (clumping) reactions are used to identify specific antigens or antibodies in blood samples.
The global Column Agglutination Test Cards market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淐olumn Agglutination Test Cards Industry Forecast鈥� looks at past sales and reviews total world Column Agglutination Test Cards sales in 2023, providing a comprehensive analysis by region and market sector of projected Column Agglutination Test Cards sales for 2024 through 2030. With Column Agglutination Test Cards sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Column Agglutination Test Cards industry.
This Insight Report provides a comprehensive analysis of the global Column Agglutination Test Cards landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Column Agglutination Test Cards portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Column Agglutination Test Cards market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Column Agglutination Test Cards and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Column Agglutination Test Cards.
The Gel Card Method is based on the principles of agglutination and hemagglutination. Agglutination is the clumping together of particles 鈥� in this case, red blood cells (RBCs). The RBCs will agglutinate when mixed with sera containing the corresponding antibodies. The degree of agglutination in the microtubes within the gel card is then used to determine the blood group.
This report presents a comprehensive overview, market shares, and growth opportunities of Column Agglutination Test Cards market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Blood Grouping Forward and Reverse Test
Cross Match Test
Other
Segmentation by Application:
Hospitals
Research Centers
Laboratory
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Grifols
Bio-Rad
Ortho Clinical Diagnostics (QuidelOrtho)
Turklab
Tulip Diagnostics (PerkinElmer)
Redcell Biotechnology
Dia Pro T谋bbi 脺r眉nler
Aikang MedTech
Tianjin Dexiang Biotech
POLYRICHE BIOTECH
Hubei Longtime Biological
Singapore BioSciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Column Agglutination Test Cards market?
What factors are driving Column Agglutination Test Cards market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Column Agglutination Test Cards market opportunities vary by end market size?
How does Column Agglutination Test Cards break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Column Agglutination Test Cards Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Column Agglutination Test Cards by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Column Agglutination Test Cards by Country/Region, 2019, 2023 & 2030
2.2 Column Agglutination Test Cards Segment by Type
2.2.1 Blood Grouping Forward and Reverse Test
2.2.2 Cross Match Test
2.2.3 Other
2.3 Column Agglutination Test Cards Sales by Type
2.3.1 Global Column Agglutination Test Cards Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Column Agglutination Test Cards Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Column Agglutination Test Cards Sale Price by Type (2019-2024)
2.4 Column Agglutination Test Cards Segment by Application
2.4.1 Hospitals
2.4.2 Research Centers
2.4.3 Laboratory
2.4.4 Others
2.5 Column Agglutination Test Cards Sales by Application
2.5.1 Global Column Agglutination Test Cards Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Column Agglutination Test Cards Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Column Agglutination Test Cards Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Column Agglutination Test Cards Breakdown Data by Company
3.1.1 Global Column Agglutination Test Cards Annual Sales by Company (2019-2024)
3.1.2 Global Column Agglutination Test Cards Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Column Agglutination Test Cards Annual Revenue by Company (2019-2024)
3.2.1 Global Column Agglutination Test Cards Revenue by Company (2019-2024)
3.2.2 Global Column Agglutination Test Cards Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Column Agglutination Test Cards Sale Price by Company
3.4 Key Manufacturers Column Agglutination Test Cards Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Column Agglutination Test Cards Product Location Distribution
3.4.2 Players Column Agglutination Test Cards Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Column Agglutination Test Cards by Geographic Region
4.1 World Historic Column Agglutination Test Cards 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Column Agglutination Test Cards Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Column Agglutination Test Cards Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Column Agglutination Test Cards 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Column Agglutination Test Cards Annual Sales by Country/Region (2019-2024)
4.2.2 Global Column Agglutination Test Cards Annual Revenue by Country/Region (2019-2024)
4.3 Americas Column Agglutination Test Cards Sales Growth
4.4 APAC Column Agglutination Test Cards Sales Growth
4.5 Europe Column Agglutination Test Cards Sales Growth
4.6 Middle East & Africa Column Agglutination Test Cards Sales Growth
5 Americas
5.1 Americas Column Agglutination Test Cards Sales by Country
5.1.1 Americas Column Agglutination Test Cards Sales by Country (2019-2024)
5.1.2 Americas Column Agglutination Test Cards Revenue by Country (2019-2024)
5.2 Americas Column Agglutination Test Cards Sales by Type (2019-2024)
5.3 Americas Column Agglutination Test Cards Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Column Agglutination Test Cards Sales by Region
6.1.1 APAC Column Agglutination Test Cards Sales by Region (2019-2024)
6.1.2 APAC Column Agglutination Test Cards Revenue by Region (2019-2024)
6.2 APAC Column Agglutination Test Cards Sales by Type (2019-2024)
6.3 APAC Column Agglutination Test Cards Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Column Agglutination Test Cards by Country
7.1.1 Europe Column Agglutination Test Cards Sales by Country (2019-2024)
7.1.2 Europe Column Agglutination Test Cards Revenue by Country (2019-2024)
7.2 Europe Column Agglutination Test Cards Sales by Type (2019-2024)
7.3 Europe Column Agglutination Test Cards Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Column Agglutination Test Cards by Country
8.1.1 Middle East & Africa Column Agglutination Test Cards Sales by Country (2019-2024)
8.1.2 Middle East & Africa Column Agglutination Test Cards Revenue by Country (2019-2024)
8.2 Middle East & Africa Column Agglutination Test Cards Sales by Type (2019-2024)
8.3 Middle East & Africa Column Agglutination Test Cards Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Column Agglutination Test Cards
10.3 Manufacturing Process Analysis of Column Agglutination Test Cards
10.4 Industry Chain Structure of Column Agglutination Test Cards
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Column Agglutination Test Cards Distributors
11.3 Column Agglutination Test Cards Customer
12 World Forecast Review for Column Agglutination Test Cards by Geographic Region
12.1 Global Column Agglutination Test Cards 麻豆原创 Size Forecast by Region
12.1.1 Global Column Agglutination Test Cards Forecast by Region (2025-2030)
12.1.2 Global Column Agglutination Test Cards Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Column Agglutination Test Cards Forecast by Type (2025-2030)
12.7 Global Column Agglutination Test Cards Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Grifols
13.1.1 Grifols Company Information
13.1.2 Grifols Column Agglutination Test Cards Product Portfolios and Specifications
13.1.3 Grifols Column Agglutination Test Cards Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Grifols Main Business Overview
13.1.5 Grifols Latest Developments
13.2 Bio-Rad
13.2.1 Bio-Rad Company Information
13.2.2 Bio-Rad Column Agglutination Test Cards Product Portfolios and Specifications
13.2.3 Bio-Rad Column Agglutination Test Cards Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bio-Rad Main Business Overview
13.2.5 Bio-Rad Latest Developments
13.3 Ortho Clinical Diagnostics (QuidelOrtho)
13.3.1 Ortho Clinical Diagnostics (QuidelOrtho) Company Information
13.3.2 Ortho Clinical Diagnostics (QuidelOrtho) Column Agglutination Test Cards Product Portfolios and Specifications
13.3.3 Ortho Clinical Diagnostics (QuidelOrtho) Column Agglutination Test Cards Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Ortho Clinical Diagnostics (QuidelOrtho) Main Business Overview
13.3.5 Ortho Clinical Diagnostics (QuidelOrtho) Latest Developments
13.4 Turklab
13.4.1 Turklab Company Information
13.4.2 Turklab Column Agglutination Test Cards Product Portfolios and Specifications
13.4.3 Turklab Column Agglutination Test Cards Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Turklab Main Business Overview
13.4.5 Turklab Latest Developments
13.5 Tulip Diagnostics (PerkinElmer)
13.5.1 Tulip Diagnostics (PerkinElmer) Company Information
13.5.2 Tulip Diagnostics (PerkinElmer) Column Agglutination Test Cards Product Portfolios and Specifications
13.5.3 Tulip Diagnostics (PerkinElmer) Column Agglutination Test Cards Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Tulip Diagnostics (PerkinElmer) Main Business Overview
13.5.5 Tulip Diagnostics (PerkinElmer) Latest Developments
13.6 Redcell Biotechnology
13.6.1 Redcell Biotechnology Company Information
13.6.2 Redcell Biotechnology Column Agglutination Test Cards Product Portfolios and Specifications
13.6.3 Redcell Biotechnology Column Agglutination Test Cards Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Redcell Biotechnology Main Business Overview
13.6.5 Redcell Biotechnology Latest Developments
13.7 Dia Pro T谋bbi 脺r眉nler
13.7.1 Dia Pro T谋bbi 脺r眉nler Company Information
13.7.2 Dia Pro T谋bbi 脺r眉nler Column Agglutination Test Cards Product Portfolios and Specifications
13.7.3 Dia Pro T谋bbi 脺r眉nler Column Agglutination Test Cards Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Dia Pro T谋bbi 脺r眉nler Main Business Overview
13.7.5 Dia Pro T谋bbi 脺r眉nler Latest Developments
13.8 Aikang MedTech
13.8.1 Aikang MedTech Company Information
13.8.2 Aikang MedTech Column Agglutination Test Cards Product Portfolios and Specifications
13.8.3 Aikang MedTech Column Agglutination Test Cards Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Aikang MedTech Main Business Overview
13.8.5 Aikang MedTech Latest Developments
13.9 Tianjin Dexiang Biotech
13.9.1 Tianjin Dexiang Biotech Company Information
13.9.2 Tianjin Dexiang Biotech Column Agglutination Test Cards Product Portfolios and Specifications
13.9.3 Tianjin Dexiang Biotech Column Agglutination Test Cards Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Tianjin Dexiang Biotech Main Business Overview
13.9.5 Tianjin Dexiang Biotech Latest Developments
13.10 POLYRICHE BIOTECH
13.10.1 POLYRICHE BIOTECH Company Information
13.10.2 POLYRICHE BIOTECH Column Agglutination Test Cards Product Portfolios and Specifications
13.10.3 POLYRICHE BIOTECH Column Agglutination Test Cards Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 POLYRICHE BIOTECH Main Business Overview
13.10.5 POLYRICHE BIOTECH Latest Developments
13.11 Hubei Longtime Biological
13.11.1 Hubei Longtime Biological Company Information
13.11.2 Hubei Longtime Biological Column Agglutination Test Cards Product Portfolios and Specifications
13.11.3 Hubei Longtime Biological Column Agglutination Test Cards Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hubei Longtime Biological Main Business Overview
13.11.5 Hubei Longtime Biological Latest Developments
13.12 Singapore BioSciences
13.12.1 Singapore BioSciences Company Information
13.12.2 Singapore BioSciences Column Agglutination Test Cards Product Portfolios and Specifications
13.12.3 Singapore BioSciences Column Agglutination Test Cards Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Singapore BioSciences Main Business Overview
13.12.5 Singapore BioSciences Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.